Javascript must be enabled to continue!
FGF independent MEK1/2 signalling is essential for male fetal germline development in mice
View through CrossRef
Abstract
Background
Germline development provides the founding cells for spermatogenesis and oogenesis in males and females, respectively. Disrupted germline differentiation or compromised testis development can lead to subfertility or infertility and are strongly associated with testis cancer in humans. In mice, SRY and SOX9 induce expression of a range of genes, including
Fgf9,
that promote Sertoli cell differentiation and testis development. FGF9 is also thought to promote male germline differentiation but the pathway through which it signals is unknown. As FGFs signal through Mitogen-Activated Protein Kinases (MAPKs) in other tissues, we explored whether FGF9 regulates male germline development through MAPK by inhibiting either FGF or MEK1/2 signalling in fetal testis cultures from embryonic day (E)12.5, immediately after gonadal sex determination and testis cord formation, but prior to male germline commitment.
Results
Inhibition of MEK1/2 disrupted mitotic arrest, dysregulated a broad range of male germline development genes and prevented the upregulation of key male germline markers DPPA4 and DNMT3L. In contrast, when FGF signalling was inhibited, the male germline specific transcriptional program and the expression of male germline markers DPPA4 and DNMT3L were unaffected, and germ cells entered mitotic arrest normally. While male germline development was not disrupted by FGF inhibition, some genes were commonly altered after 24h of FGF or MEK1/2 inhibition including genes involved in maintenance, germline stem cells, Nodal signalling, proliferation, and germline cancer.
Conclusions
Together, these data demonstrate a novel and essential role for MEK1/2 signalling in male germline differentiation, but a more limited role for FGF signalling. Our data strongly indicate that additional ligands act through MEK1/2 to promote male germline differentiation and highlight a need for further mechanistic understanding of male germline development.
Title: FGF independent MEK1/2 signalling is essential for male fetal germline development in mice
Description:
Abstract
Background
Germline development provides the founding cells for spermatogenesis and oogenesis in males and females, respectively.
Disrupted germline differentiation or compromised testis development can lead to subfertility or infertility and are strongly associated with testis cancer in humans.
In mice, SRY and SOX9 induce expression of a range of genes, including
Fgf9,
that promote Sertoli cell differentiation and testis development.
FGF9 is also thought to promote male germline differentiation but the pathway through which it signals is unknown.
As FGFs signal through Mitogen-Activated Protein Kinases (MAPKs) in other tissues, we explored whether FGF9 regulates male germline development through MAPK by inhibiting either FGF or MEK1/2 signalling in fetal testis cultures from embryonic day (E)12.
5, immediately after gonadal sex determination and testis cord formation, but prior to male germline commitment.
Results
Inhibition of MEK1/2 disrupted mitotic arrest, dysregulated a broad range of male germline development genes and prevented the upregulation of key male germline markers DPPA4 and DNMT3L.
In contrast, when FGF signalling was inhibited, the male germline specific transcriptional program and the expression of male germline markers DPPA4 and DNMT3L were unaffected, and germ cells entered mitotic arrest normally.
While male germline development was not disrupted by FGF inhibition, some genes were commonly altered after 24h of FGF or MEK1/2 inhibition including genes involved in maintenance, germline stem cells, Nodal signalling, proliferation, and germline cancer.
Conclusions
Together, these data demonstrate a novel and essential role for MEK1/2 signalling in male germline differentiation, but a more limited role for FGF signalling.
Our data strongly indicate that additional ligands act through MEK1/2 to promote male germline differentiation and highlight a need for further mechanistic understanding of male germline development.
Related Results
Expression of osteoclastogenic factor transcripts in osteoblast‐like UMR‐106 cells after exposure to FGF‐23 or FGF‐23 combined with parathyroid hormone
Expression of osteoclastogenic factor transcripts in osteoblast‐like UMR‐106 cells after exposure to FGF‐23 or FGF‐23 combined with parathyroid hormone
AbstractAs a bone‐derived hormone, fibroblast growth factor‐23 (FGF‐23) negatively regulates phosphate and calcium metabolism, while retaining growth‐promoting action for mesenchym...
Negative Regulation by p70 S6 Kinase of FGF-2–Stimulated VEGF Release Through Stress-Activated Protein Kinase/c-Jun N-Terminal Kinase in Osteoblasts
Negative Regulation by p70 S6 Kinase of FGF-2–Stimulated VEGF Release Through Stress-Activated Protein Kinase/c-Jun N-Terminal Kinase in Osteoblasts
Abstract
To clarify the mechanism of VEGF release in osteoblasts, we studied whether p70 S6 kinase is involved in basic FGF-2–stimulated VEGF release in osteoblast-l...
Allosteric Kinase Inhibitors Reshape MEK1 Kinase Activity Conformations in Cells and In Silico
Allosteric Kinase Inhibitors Reshape MEK1 Kinase Activity Conformations in Cells and In Silico
Mutations at different stages of the mitogen-activated protein kinase (MAPK) signaling pathway lead to aberrant activation of the involved protein kinase entities. These oncogenic ...
The prognostic impact of fibroblast growth factor-23 on cardiovascular death after cardiac surgery
The prognostic impact of fibroblast growth factor-23 on cardiovascular death after cardiac surgery
Abstract
Background
Fibroblast growth factor 23 (FGF-23) participates in phosphate and vitamin D metabolism and proved to be ass...
Long-Pentraxin 3 Affects Primary Cilium in Zebrafish Embryo and Cancer Cells via the FGF System
Long-Pentraxin 3 Affects Primary Cilium in Zebrafish Embryo and Cancer Cells via the FGF System
Primary cilium drives the left-right asymmetry process during embryonic development. Moreover, its dysregulation contributes to cancer progression by affecting various signaling pa...
RETROGRADE CORONARY VENOUS DELIVERY OF FIBROBLAST GROWTH FACTOR-2 ENHANCES IN VIVO HOMING AND DIFFERENTIATION OF MESENCHYMAL STEM CELLS
RETROGRADE CORONARY VENOUS DELIVERY OF FIBROBLAST GROWTH FACTOR-2 ENHANCES IN VIVO HOMING AND DIFFERENTIATION OF MESENCHYMAL STEM CELLS
Objectives
In vitro studies showed fibroblast growth factor-2 (FGF-2) controls migration of mesenchymal stem cells (MSCs). In the present study, we established co...
Blood fibroblast growth factor 23 concentration in cats with and without chronic kidney disease: a scoping review
Blood fibroblast growth factor 23 concentration in cats with and without chronic kidney disease: a scoping review
Objectives
This study undertook a scoping review of research on blood fibroblast growth factor 23 (FGF-23) concentrations in healthy non-azotemic cats and cats ...
Controlled release of FGF‐2 using fragmin/protamine microparticles and effect on neovascularization
Controlled release of FGF‐2 using fragmin/protamine microparticles and effect on neovascularization
AbstractWater‐insoluble fragmin/protamine microparticles of about 0.5–1 μm in diameter were prepared by simple mixing of low‐molecular‐weight heparin (fragmin) with protamine. We i...

